Whereas the study by Rummel and colleagues [19] found no association between PSPHL loss or retention and pathological characteristics, in our study, PSPHL expression was associated with grade, tumor size, ER/PR status, and breast cancer PAM50 subtype [19]. Here, ESR1 is linked to breast carcinoma.